Medicare Enrolled
Dr. Jamal Razzack, M.D.
Pulmonary Disease · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Razzack from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razzack?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Razzack
Dr. Jamal Razzack is a pulmonary disease specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Razzack performed 7,105 Medicare services across 2,543 unique beneficiaries.
Between the years covered by Open Payments, Dr. Razzack received a total of $12,530 from 47 pharmaceutical and/or device companies across 507 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razzack is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in TX
$12,530 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,105
Medicare services
Top 2% in TX for pulmonary disease
2,543
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~355 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,361 | $3 | $10 |
| Respiratory muscle strengthening therapy, per 15 min One-on-one therapy to improve the strength or endurance of respiratory muscles. The session includes monitoring and is billed for each 15-minute increment. |
695 | $8 | $11 |
| Therapeutic respiratory procedure, 15 minutes A one-on-one, face-to-face therapeutic procedure designed to improve respiratory function. The session includes monitoring and is billed per 15 minutes. |
695 | $8 | $12 |
| Outpatient pulmonary rehabilitation with oxygen monitoring A supervised outpatient session for pulmonary rehabilitation that includes continuous monitoring of blood oxygen levels. |
573 | $60 | $146 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
490 | $171 | $358 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
464 | $86 | $204 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
416 | $96 | $204 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
366 | $45 | $148 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
365 | $31 | $148 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
365 | $43 | $148 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
339 | $4 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
280 | $95 | $205 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
232 | $140 | $280 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
106 | $484 | $2,200 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
89 | $26 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
88 | $140 | $256 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
50 | $503 | $2,200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $69 | $110 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
36 | $26 | $100 |
| Electronic analysis of neurostimulator generator An electronic check of the neurostimulator device to review its function and settings. |
20 | $31 | $102 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves electronically analyzing an implanted neurostimulator generator and performing complex programming for a cranial nerve stimulator. |
17 | $43 | $121 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
15 | $70 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,530
Total received (2018-2024)
Avg $1,790/year across 7 years
Top 16% in TX for pulmonary disease
47
Companies
507
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,254 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$276 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,376
2023
$1,698
2022
$4,020
2021
$1,517
2020
$808
2019
$947
2018
$1,164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pulmonx Corporation
$2,937
Inspire Medical Systems, Inc.
$1,806
GlaxoSmithKline, LLC.
$998
AstraZeneca Pharmaceuticals LP
$952
Electromed, Inc.
$738
Boehringer Ingelheim Pharmaceuticals, Inc.
$648
Philips Electronics North America Corporation
$451
Mylan Specialty L.P.
$445
Insmed, Inc.
$406
Sunovion Pharmaceuticals Inc.
$396
Janssen Pharmaceuticals, Inc
$252
Astellas Pharma US Inc
$223
Actelion Pharmaceuticals US, Inc.
$221
GENZYME CORPORATION
$218
Genentech USA, Inc.
$178
Harmony Biosciences LLC
$162
Teva Pharmaceuticals USA, Inc.
$127
Merck Sharp & Dohme LLC
$124
Intuitive Surgical, Inc.
$123
BOSTON SCIENTIFIC CORPORATION
$106
Regeneron Healthcare Solutions, Inc.
$101
Melinta Therapeutics, LLC
$79
ARBOR PHARMACEUTICALS, INC.
$77
Merck Sharp & Dohme Corporation
$67
Jazz Pharmaceuticals Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$55
ABIOMED
$54
Medtronic Vascular, Inc.
$50
Mallinckrodt Hospital Products Inc.
$48
Edwards Lifesciences Corporation
$46
Paratek Pharmaceuticals, Inc.
$45
Avadel CNS Pharmaceuticals, LLC
$38
Allergan Inc.
$36
Shionogi Inc
$33
Axsome Therapeutics, Inc.
$30
Arbor Pharmaceuticals, Inc.
$25
Alcresta Therapeutics, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$22
Tactile Systems Technology Inc
$19
Allergan, Inc.
$18
Nabriva Therapeutics, plc
$17
Amgen Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Vapotherm Inc
$15
Boston Scientific Corporation
$15
Philips North America LLC
$13
United Therapeutics Corporation
$5
Top 3 companies account for 45.8% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8685) OEM Other · (8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · 3F · ACTHAR · AIRSUPRA · AMBISOME · ANORO · APTIOM · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CRESEMBA · CUVITRU · DUPIXENT · Da Vinci Surgical System · Dymista · ELIQUIS · EXALT Model D · Esbriet · FARXIGA · FASENRA · Fetroja · Flexitouch Plus · GENERAL VASCULAR INTERVENTION · GLASSIA · HemoSphere · Horizant · INSPIRE · Impella · Inspire Upper Airway Stimulation System · JARDIANCE · LONHALA MAGNAIR · LUMRYZ · MYCAMINE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Precision Flow · Pulmonx Endobronchial Valve EBV · RECARBRIO · RELIZORB · Respiratoriy Care Undiv · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · UPTRAVI · Utibron · Vabomere · Wakix · Wellcentive Undiv · XARELTO · Xenleta · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $176 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
118
Per 100K population
2.5
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE WEST
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Razzack is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement in the top 16% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Razzack experienced with allergy skin test?
Based on Medicare claims data, Dr. Razzack performed 1,361 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Razzack receive payments from pharmaceutical companies?
Yes. Dr. Razzack received a total of $12,530 from 47 companies across 507 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razzack's costs compare to other pulmonary diseases in Houston?
Dr. Razzack's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razzack) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Houston
Browse pulmonary diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
Pulmonx Corporation Payments to Doctors
See all physicians who received payments from Pulmonx Corporation.
By company
Inspire Medical Systems, Inc. Payments to Doctors
See all physicians who received payments from Inspire Medical Systems, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology